| Robin Collins, | |
|
1000 Pennsylvania Ave, Claymont, DE 19703-1200 | |
| (302) 792-3994 | |
| Not Available |
| Full Name | Robin Collins |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - School |
| Location | 1000 Pennsylvania Ave, Claymont, Delaware |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215071105 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WS0200X | Registered Nurse - School | L10015102 (Delaware) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Robin Collins, 1000 Pennsylvania Ave, Claymont, DE 19703-1200 Ph: () - | Robin Collins, 1000 Pennsylvania Ave, Claymont, DE 19703-1200 Ph: (302) 792-3994 |
News Archive
BioLineRx Ltd., a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that it has received confirmation from the European Notified Body regarding the classification of BL-7010, a novel polymer for the treatment of celiac disease, as a Class IIb medical device in the European Union.
Pharmacyclics, Inc. announced today that the U.S. Food and Drug Administration has granted an additional Breakthrough Therapy Designation for the investigational oral agent ibrutinib as monotherapy for the treatment of chronic lymphocytic leukemia or small lymphocytic lymphoma patients with deletion of the short arm of chromosome 17 (deletion 17p).
Parents who give young children prescription painkillers should take extra care to make sure they give just the right amount. What they may be surprised to learn, however, is that the dose given to them by the pharmacy could be too high, according to research to be presented Saturday, April 30, at the Pediatric Academic Societies annual meeting in Denver.
Journal of the American Medical Association: Funding of US Biomedical Research, 2003-2008 - After doubling in a decade, the rate of increase in biomedical research in the U.S. has slowed since 2005, and the level of funding from the National Institutes of Health and industry appears to have decreased by 2 percent in 2008, after adjusting for inflation, the authors of this study report.
Clinigen Group plc ('Clinigen' or the 'Group') the specialty global pharmaceutical company today announces the acquisition of SAVENE® (dexrazoxane) from SpePharm AG, a majority owned affiliate of Norgine B.V. The Financial terms of the acquisition are not being disclosed.
› Verified 6 days ago
Patricia Guilday, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1000 Pennsylvania Ave, Claymont, DE 19703 Phone: 302-792-3994 | |
Rhealinda Johnson, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1000 Pennsylvania Ave, Claymont, DE 19703 Phone: 302-792-3994 | |
Karen Reed, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3301 Green St, Claymont, DE 19703 Phone: 302-374-0688 Fax: 302-792-2712 | |
Gloria Boyd, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3301 Green St, Claymont, DE 19703 Phone: 302-439-4951 | |
Denise Elliott, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1000 Pennsylvania Ave, Claymont, DE 19703 Phone: 302-792-3994 | |
Karen L. Pennington, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1000 Pennsylvania Ave, Claymont, DE 19703 Phone: 302-792-3937 | |
Eileen Mclaurin, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1000 Pennsylvania Ave, Claymont, DE 19703 Phone: 302-792-3936 |